Jan De Witte

Jan De Witte is recorded as Board Member at Resmed Inc (RMD). The newest filing on record that lists Jan De Witte as Board Member at Resmed Inc (RMD) is dated October 1, 2026. Earlier roles on record: CEO and Board Member at Integra Lifesciences Holdings Corp (IART) until January 6, 2025 and Board Member at Integra Lifesciences Holdings Corp (IART) until February 28, 2024. Resmed Inc reported in an 8-K filed November 20, 2025 that Jan De Witte was appointed Director, effective November 19, 2025. Integra Lifesciences Holdings Corp reported in an 8-K filed November 4, 2024 that Jan De Witte resigned as director, effective January 6, 2025. Integra Lifesciences Holdings Corp reported in an 8-K filed November 4, 2024 that Jan De Witte resigned as President and Chief Executive Officer, effective January 6, 2025. Equibles holds 6 filed executive changes naming Jan De Witte; each is listed under recent activity with its source filing. The proxy statement of Integra Lifesciences Holdings Corp reports total compensation of $282,679 for Jan De Witte in fiscal 2025, including a base salary of $42,308. Disclosed compensation is on record for 5 fiscal years. Jan De Witte has spoken on 12 earnings calls across 1 company, most recently for Integra Lifesciences Holdings Corp on November 4, 2024. Resmed Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other companies whose calls Jan De Witte spoke on are classified in the Healthcare sector. Other leadership on record at Resmed Inc includes Michael J. "Mick" Farrell (Chairman), Aaron Bloomer (CFO and Board Member), Mike Rider (General Counsel) and 7 others.